Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Vertex Pharmaceuticals (NQ:VRTX)

463.48 +2.24 (+0.49%)
Streaming Delayed Price Updated: 9:42 AM EST, Feb 12, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 64,526
Open 462.00
Bid (Size) 462.66 (40)
Ask (Size) 464.30 (40)
Prev. Close 461.24
Today's Range 460.00 - 466.04
52wk Range 362.50 - 519.68
Shares Outstanding 259,428,394
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Vertex Pharmaceuticals (VRTX) Q4 Earnings: What To Expect
Via StockStory
Topics Artificial Intelligence World Trade
News headline image
1 Reason I'd Buy Vertex Pharmaceuticals Stock and Never Sell ↗
Vertex stock has climbed more than 60% over three years. 
Via The Motley Fool
Topics Intellectual Property

Performance

YTD
+2.5%
+2.5%
1 Month
+0.6%
+0.6%
3 Month
+6.7%
+6.7%
6 Month
+17.1%
+17.1%
1 Year
+1.8%
+1.8%

More News

Read More
News headline image
Should You Buy Vertex Before Feb. 12? ↗
Via The Motley Fool
Topics Intellectual Property
News headline image
Provident Dumps 490,000 MapleBear Shares Worth $18 Million ↗
Via The Motley Fool
Topics Regulatory Compliance
Vertex Pharmaceuticals Inc (NASDAQ:VRTX) Presents a Compelling Growth and Breakout Opportunity ↗
Via Chartmill
Vertex Pharmaceuticals Inc. (NASDAQ:VRTX) Presents a Compelling Value Case ↗
Via Chartmill
Vertex Pharmaceuticals Inc (NASDAQ:VRTX) Emerges as a Prime GARP Investment Candidate ↗
Via Chartmill
News headline image
Should You Buy Vertex Pharmaceuticals Before Feb. 12? ↗
Via The Motley Fool
News headline image
The Bond Market Is Flashing a Clear Warning About the Fed: 3 Stocks to Buy ↗
Via The Motley Fool
Topics Bonds Economy Government
News headline image
2 Top Healthcare Stocks to Buy in February ↗
Via The Motley Fool
Topics World Trade
News headline image
The Great Pipeline Grab: Life Sciences Deal Volume Skyrockets 82% as Big Pharma Battles the Patent Cliff
Via MarketMinute
Topics Artificial Intelligence Economy Intellectual Property
News headline image
3 Market-Beating Stocks Worth Investigating
Via StockStory
News headline image
Prediction: 2026 Will Be the Year of Vertex Pharmaceuticals ↗
Via The Motley Fool
News headline image
1 Healthcare Stock to Consider Right Now and 2 We Brush Off
Via StockStory
Topics Stocks
News headline image
Breaking Barriers: How 2026’s Top Clinical Leaders Are Disrupting Chronic Disease Markets
From Equity Insider
Via GlobeNewswire
News headline image
Reflecting On Therapeutics Stocks’ Q3 Earnings: Vertex Pharmaceuticals (NASDAQ:VRTX)
Via StockStory
Topics Artificial Intelligence
News headline image
Vertex to Announce Fourth Quarter and Full Year 2025 Financial Results on February 12th
From Vertex Pharmaceuticals Incorporated
Via Business Wire
News headline image
Unpacking Q3 Earnings: Vertex Pharmaceuticals (NASDAQ:VRTX) In The Context Of Other Therapeutics Stocks
Via StockStory
Topics Artificial Intelligence
News headline image
My Forever Portfolio: 5 Stocks I Don't Plan on Ever Selling ↗
Via The Motley Fool
Topics Artificial Intelligence
News headline image
3 Profitable Stocks with Open Questions
Via StockStory
News headline image
Prediction: These Could Be the Best-Performing Healthcare Stocks Through 2030 ↗
Via The Motley Fool
News headline image
Travere Therapeutics Shares Fall After FDA Extends Filspari Review for FSGS
Via MarketMinute
News headline image
Vertex Provides Pipeline and Business Updates in Advance of Upcoming Investor Meetings
From Vertex Pharmaceuticals Incorporated
Via Business Wire
News headline image
The Best Stocks to Invest $50,000 in Right Now ↗
Via The Motley Fool
Topics Artificial Intelligence
News headline image
Cashing In at the Peak: Olema Pharmaceuticals Insiders Sell $8 Million in Stock After 300% Surge
Via MarketMinute

Frequently Asked Questions

Is Vertex Pharmaceuticals publicly traded?
Yes, Vertex Pharmaceuticals is publicly traded.
What exchange does Vertex Pharmaceuticals trade on?
Vertex Pharmaceuticals trades on the Nasdaq Stock Market
What is the ticker symbol for Vertex Pharmaceuticals?
The ticker symbol for Vertex Pharmaceuticals is VRTX on the Nasdaq Stock Market
What is the current price of Vertex Pharmaceuticals?
The current price of Vertex Pharmaceuticals is 463.48
When was Vertex Pharmaceuticals last traded?
The last trade of Vertex Pharmaceuticals was at 02/12/26 09:42 AM ET
What is the market capitalization of Vertex Pharmaceuticals?
The market capitalization of Vertex Pharmaceuticals is 120.24B
How many shares of Vertex Pharmaceuticals are outstanding?
Vertex Pharmaceuticals has 120B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

© Copyright 2015, Penticton Herald, Penticton, BC. Powered by BLOX Content Management System from TownNews.com.